• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- Type 2 diabetes rates in US youth rose 62% after COVID pandemic began, study suggests

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/covid-19...-62-after-covid-pandemic-began-study-suggests

Type 2 diabetes rates in US youth rose 62% after COVID pandemic began, study suggests



Mary Van Beusekom, MS


Today at 1:04 p.m.

COVID-19
Rates of new-onset type 2 diabetes climbed 62%—and type 1 diabetes increased 17%—among US youth after the COVID-19 pandemic began, especially in Black and Hispanic children, according to a study published yesterday in JAMA Network Open.

For the study, Kaiser Permanente researchers tracked rates of type 1 and type 2 diabetes among health system members aged 0 to 19 years in southern California with no history of diabetes from January 2016 to December 2021.

"Youth-onset diabetes is a serious chronic health condition, placing individuals at risk for early complications, comorbidities, and excess mortality, in particular among those who develop type 2 diabetes and those from racial and ethnic minority groups such as non-Hispanic Black individuals," the study authors wrote.

Kids aged 10 to 19 years especially affected


Over the study period, 1,200 youth were diagnosed as having type 1 diabetes, 1,100 diagnosed with type 2 diabetes, and 63 patients with "other" diabetes. Type 1 diabetes rates climbed from 18.5 per 100,000 person-years in 2016 to 2019 to 22.4 per 100,000 person-years from 2020 to 2021.

Relative to 2016 to 2019, in 2020 to 2021, the incidence of new-onset type 1 diabetes was 17% higher (incidence rate ratio [IRR], 1.17). The incidence was higher among patients aged 10 to 19 years (IRR,1.17), boys (IRR, 1.18), and Hispanic patients (1.21).

Rates of type 2 diabetes were 62% higher (IRR, 1.62) in 2020 to 2021 than in 2016 to 2019. The incidence of type 2 diabetes rose from 14.8 to 24.7 per 100,000 person-years over that time.

Rates were higher among patients aged 10 to 19 years (IRR, 1.63), girls (IRR, 1.44), boys (IRR, 1.83), Black patients (IRR, 1.95), Hispanic patients (IRR, 1.61), and other/unknown racial groups (IRR, 2.96). The incidence rate differences followed similar patterns for both type 1 and type 2 diabetes.

Black, Hispanic patients had heavy diabetes burden


By quarter, rates of type 1 diabetes fluctuated seasonally but climbed among patients aged 10 to 19 years in Q1 of 2021. Among youth with type 2 diabetes, a spike in incidence occurred in Q3 and Q4 of 2020, especially among Black and Hispanic patients, which the researchers said suggests that they bore a disproportionate burden of type 2 diabetes.

Diabetes risk factors may have been exacerbated during the COVID-19 pandemic including limited physical activity, increased sedentary behaviors, sleep disturbances, and increased intake of processed foods.

Sociodemographic factors, average body mass index, fasting and random glucose levels, and hemoglobin A[SUB]1c[/SUB] concentrations didn't change from 2016 to 2021.

The authors noted that research has shown that coronavirus-binding via angiotensin-converting enzyme 2 (ACE2) receptors damages islet cells in the pancreas and may lead to diabetes.

"Hyperglycemia and insulin resistance have been noted in patients with COVID-19 infection without prior indicators of diabetes risk," they wrote. "Additionally, diabetes risk factors may have been exacerbated during the COVID-19 pandemic including limited physical activity, increased sedentary behaviors, sleep disturbances, and increased intake of processed foods."

The findings, they added, point to the need for future research on physiologic and behavioral risk factors for new-onset diabetes before and during the pandemic.
 
Back
Top Bottom